stocks logo

LFST

LifeStance Health Group Inc
$
4.140
0(0.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.195
Open
4.190
VWAP
4.14
Vol
1.83M
Mkt Cap
1.61B
Low
4.100
Amount
7.59M
EV/EBITDA(TTM)
34.19
Total Shares
382.29M
EV
1.76B
EV/OCF(TTM)
13.98
P/S(TTM)
1.23
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
374.50M
+15.05%
--
--
358.37M
+14.6%
--
--
345.08M
+10.49%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for LifeStance Health Group, Inc. (LFST) for FY2025, with the revenue forecasts being adjusted by -0.31% over the past three months. During the same period, the stock price has changed by -36.60%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.31%
In Past 3 Month
Stock Price
Go Down
down Image
-36.60%
In Past 3 Month
6 Analyst Rating
up Image
110.14% Upside
Wall Street analysts forecast LFST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFST is 8.70 USD with a low forecast of 8.00 USD and a high forecast of 10.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
0 Sell
Strong Buy
up Image
110.14% Upside
Current: 4.140
sliders
Low
8.00
Averages
8.70
High
10.00
BTIG
Buy
initiated
$8
2025-07-25
New
Reason
BTIG initiated coverage of LifeStance with a Buy rating and $8 price target. The firm says LifeStance is one of the country's largest outpatient mental health providers. It notes that 90% of the company's patients are commercially insured, making it well networked into health systems and referring hospitals. BTIG believes commercially insured lives are the most attractive segment of the market since insurance rates are typically well above Medicare and Medicaid rates. LifeStance is differentiated given its in-person and virtual care model, the analyst tells investors in a research note.
UBS
Kevin Caliendo
Neutral -> Buy
upgrade
$8.50
2025-05-27
Reason
Keybanc
Steve Dechert
Buy
Initiates
$9
2025-04-08
Reason
KeyBanc initiated coverage of LifeStance with an Overweight rating and $9 price target. The firm expects mid-teens organic sales growth over the next couple of years from the company, driven mainly by higher visit volumes on further clinician adds and increasing total revenue per visit on payor reimbursement rate improvement. It also expects margin expansion on the company's recently optimized real estate footprint, clinician productivity, higher margin specialty offerings, and continued cost efficiencies driven by technology enhancements.
Canaccord Genuity
Richard Close
Strong Buy
Initiates
$8
2025-04-03
Reason
Canaccord analyst Richard Close initiated coverage of LifeStance with a Buy rating and $8 price target. LifeStance is the largest clinic-based therapy provider, serving its clients both through in-person and virtual visits, the analyst tells investors in a research note. The firm says the company offers the only hybrid, in-person and virtual therapy company to invest in. It believes LifeStance's acquisition strategy offers growth upside.
Goldman Sachs
Jamie Perse
Hold
to
Strong Buy
Upgrades
$10
2024-12-16
Reason
Barclays
Stephanie Davis
Sell
Maintains
$6 → $7
2024-11-11
Reason

Valuation Metrics

The current forward P/E ratio for LifeStance Health Group Inc (LFST.O) is -106.43, compared to its 5-year average forward P/E of -32.28. For a more detailed relative valuation and DCF analysis to assess LifeStance Health Group Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-32.28
Current PE
-106.43
Overvalued PE
-3.04
Undervalued PE
-61.53

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
47.86
Current EV/EBITDA
13.99
Overvalued EV/EBITDA
81.40
Undervalued EV/EBITDA
14.31

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.10
Current PS
1.14
Overvalued PS
5.39
Undervalued PS
0.80

Financials

Annual
Quarterly
FY2025Q1
YoY :
+10.83%
332.97M
Total Revenue
FY2025Q1
YoY :
-113.22%
2.04M
Operating Profit
FY2025Q1
YoY :
-103.36%
709.00K
Net Income after Tax
FY2025Q1
YoY :
-100.00%
0.00
EPS - Diluted
FY2025Q1
YoY :
-61.92%
-10.26M
Free Cash Flow
FY2025Q1
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2025Q1
YoY :
-228.09%
7.98
FCF Margin - %
FY2025Q1
YoY :
-102.99%
0.21
Net Margin - %

Trading Trends

Insider
Insiders areSelling! The selling amount has increased 318.77% over the last month.
Sold
0-3
Months
144.3K
USD
2
3-6
Months
428.8K
USD
5
6-9
Months
644.0K
USD
2
0-12
Months
33.1K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
932.2K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

LFST News & Events

Events Timeline

2025-05-14 (ET)
2025-05-14
09:01:42
LifeStance appoints Vaughn Paunovich as CTO
select
2025-05-07 (ET)
2025-05-07
06:07:23
LifeStance still sees 2025 revenue $1.40B-$1.44B, consensus $1.42B
select
2025-05-07
06:05:54
LifeStance reports Q1 EPS 0c vs. (6c) last year
select
Sign Up For More Events

News

4.0
06-27NASDAQ.COM
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
4.0
05-28TipRanks
3 Best Stocks to Buy Now, 5/28/2025, According to Top Analysts
6.0
05-27TipRanks
“50% Upside” Possible for Lifestance Health Stock (NASDAQ:LFST), Shares Surge
Sign Up For More News

FAQ

arrow icon

What is LifeStance Health Group Inc (LFST) stock price today?

The current price of LFST is 4.14 USD — it has increased 0 % in the last trading day.

arrow icon

What is LifeStance Health Group Inc (LFST)'s business?

arrow icon

What is the price predicton of LFST Stock?

arrow icon

What is LifeStance Health Group Inc (LFST)'s revenue for the last quarter?

arrow icon

What is LifeStance Health Group Inc (LFST)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for LifeStance Health Group Inc (LFST)'s fundamentals?

arrow icon

How many employees does LifeStance Health Group Inc (LFST). have?

arrow icon

What is LifeStance Health Group Inc (LFST) market cap?